IHV Researchers in Basic Science and Vaccine Development seek a deeper understanding of the properties of chronic viral diseases to develop preventative medicines and vaccinations.
In particular, IHV’s quest includes finding an effective and affordable vaccine against HIV. This ambitious goal represents science's greatest hope in conquering the HIV/AIDS epidemic, especially in developing countries where health care is sporadic and money and medical personnel are scarce.
Scientists in this division are working on novel approaches to HIV drug therapy and an AIDS vaccine that already have shown positive results in the laboratory setting.
The Institute houses its own µQUANT core facility to provide quality immunological analyses of biological analyses to researchers within the IHV and to outside collaborators locally and nationally.